Andreu Soldevila is a highly experienced professional in the biotechnology and biopharmaceutical sectors, currently serving as the CEO of Syna Therapeutics since January 2018, focusing on the development of biosimilars. As the Chairman and Founder of Leanbio Pro since April 2014, Andreu Soldevila has led initiatives in biotech bioproduction, including bioprocess and analytical development. Previous roles include R&D Head of Department at 3p Biopharmaceuticals, where Andreu Soldevila specialized in biosimilars and vaccine development, and Head of the Protein Bio-Analysis department at IPSEN PHARMA, establishing bioanalysis platforms for biotherapeutics. Earlier in the career, Andreu Soldevila coordinated the Biotechnology department at Inkemia, conducting research in small molecule development and teaching microbiology and biotechnology. Andreu Soldevila holds a PhD in Biotechnology from Universitat Autònoma de Barcelona and a BS in Biotechnology from UVIC.
This person is not in the org chart
This person is not in any teams
This person is not in any offices